Clinical trial
Randomised Controlled Trial of Percutaneous Transluminal Angioplasty (PTA) Versus a Supervised Exercise Programme (SEP) in the Management of Intermittent Claudication (IC) Due to Femoro-popliteal Disease
NCT00798850 is registered in ClinicalTrials.gov with Hull University Teaching Hospitals NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised Controlled Trial of Percutaneous Transluminal Angioplasty (PTA) Versus a Supervised Exercise Programme (SEP) in the Management of Intermittent Claudication (IC) Due to Femoro-popliteal Disease
- Lead sponsor
- Hull University Teaching Hospitals NHS Trust
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 31, 2002
- Completion date
- November 30, 2010
- Enrollment
- 178 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
femoropopliteal disease, intermittent claudication